Clinical Trials Browser

Phase 2 × Terminated × pyrotinib × Clear all

NCT04066790 2020-05-19

Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Phase 2 Terminated

Breast Neoplasms